MOST NOTEWORTHY: SuccessFactors, Taleo and Penn National were today's noteworthy initiations:

• Oppenheimer initiated SuccessFactors Inc (NASDAQ: SFSF) with an Outperform rating and $15 target. The firm believes the company's double-digit revenue growth will continue as its differentiated HCM solutions gain broad-based adoption. Deutsche Bank believes the company has a strong opportunity to build a highly profitable business as it broadens its footprint, and started shares with a Buy rating and $15 target.
• Deutsche Bank also reinstated coverage of Taleo Corporation (NASDAQ: TLEO) with a Buy rating and $35 target. The firm believes the Vurv acquisition will create significant accretion in 2009 and that investors should take advantage of the recent share weakness.
• Oppenheimer assumed coverage of Penn National Gaming Inc (NASDAQ: PENN) with an Outperform rating and believes the termination of Penn's acquisition by Fortress Investment and Centerbridge will be catalysts for the stock, as they think it provides the company with financial flexibility. In addition, the firm believes Penn's management team has historically made prudent capital decisions.

OTHER INITIATIONS:

• Petrobras Brasileiro SA (NYSE: PBR) was initiated with a Buy rating and $92 target at Goldman.
• Cowen resumed coverage of LeMaitre Vascular Inc (NASDAQ: LMAT) with an Outperform rating.
• Sanofi-Aventis SA (NYSE: SNY) was started at ING with a Hold rating.

Here are some highlights from this past week's earnings coverage from BloggingStocks:

• Andersons Inc. (NASDAQ: ANDE) lifted its outlook on improved performance of its Plant Nutrient Group.
• BP Plc (NYSE: BP) was upgraded by Societe Generale due in part to its earnings prospects.
• Citigroup Inc. (NYSE: C) has developed an earnings improvement plan based on collective bonuses.
• Corel Corp. (NASDAQ: CREL) solid Q2 results did not address a buyout offer from Vector Capital.
• Discover Financial Services (NYSE: DFS) Q2 earnings were boosted by dumping its Goldfish card division.
• Fortune Brands Inc. (NYSE: FO) lowered its earnings outlook on challenging consumer environment.
• Isle of Capri Casinos Inc. (NASDAQ: ISLE) blamed dismal results on floods and smoking bans.
• MSCI Inc. (NYSE: MXB) strong Q2 results didn't save it from being dumped by Morgan Stanley (NYSE: MS).
• PAREXEL International Corp. (NASDAQ: PRXL) lifted its Q4 and full-year guidance, leading to an upgrade.
• Texas Industries Inc. (NYSE: TXI) was downgraded due to fears about its earnings prospects.
• Taleo Corp. (NASDAQ: TLEO) reaffirmed its outlook as an acquisition would boost results.
• WD-40 Co. (NASDAQ: WDFC) posted solid Q3 results and offered conservative guidance.

More highlights from this past week: Apollo Group, Family Dollar, Kroger, Deutsche Bank and others

Also, while Jim Cramer ponders what will signal the bottom, many investors will be looking at next week's earnings results for General Electric (NYSE: GE), the world's largest conglomerate, as a sign of the direction of the global market. And BusinessWeek reminds us that cheap stocks -- even with big names such as Ford Motor Co. (NYSE: F), Sprint Nextel Corp. (NYSE: S), and Northwest Airlines (NYSE: NWA) -- are no bargain if they have no earnings.

Upcoming results to watch for include Alcoa (NYSE: AA), Pepsi Bottling Group (NYSE: PBG), Marriott International (NYSE: MAR), and General Electric (NYSE: GE).

Visit AOL Money & Finance for more earnings coverage.

Corporate strategy expert Sramana Mitra had a nice post yesterday that looked at a broad spectrum of the burgeoning Software as a Service (SaaS) market. Companies like salesforce.com, Inc. (NYSE: CRM) are revolutionizing the software industry by providing hosted versions of traditional software packages and essentially renting them to customers. Customers benefit by paying less money upfront and don't assume the cost of ownership, opting instead to rent software from SaaS companies. Updating and maintenance of software is handled by SaaS firm.

I've been looking at Concur Technologies, Inc. (Nasdaq: CNQR). Concur's solutions address automate corporate travel and expense management. Larry Schutts had a good post on the firm saying:

Its flagship program provides the process and information for management to reduce manual processing, improve internal controls, increase business policy compliance, speed up reimbursement, and increase expense report accuracy. The software features Web-based modules for tracking, submitting, and processing reports.

Large corporations like The Chubb Corporation (NYSE: CB), J.C. Penney Company, Inc. (NYSE: JCP) and Texas Instruments Incorporated (NYSE: TXN) are all looking to 1) manage complicated expense processing 2) lower costs.

SaaS companies are just in their infancy as more business look to rent rather than buy. Check out Taleo Corporation (Nasdaq: TLEO), RightNow Technologies (Nasdaq: RNOW), and Vocus, Inc. (Nasdaq: VOCS).

Zack Miller is the managing editor of IsraelNewsletter.com and a former equity analyst for a leading multinational hedge fund.

Dell Inc. (NASDAQ: DELL) has struck again -- that is, another acquisition. This time, Dell purchased Everdream, a privately-held firm based in Fremont, California. The price tag was not disclosed.

Started in the heyday of the internet, Everdream has displayed staying power. The company has been able to build software tools that allow for remote management of computers -- such as dealing with patches, backups, and antivirus updates. The company uses an on-demand approach, which is gaining lots of traction in the tech sector. Just look at the success of companies like Salesforce.com (NYSE: CRM), NetSuite, and Taleo Corp. (NASDAQ: TLEO).

Currently, Everdream manages about 140,000 desktops. Although, with the power of Dell, that footprint will likely spike. What's more, the deal should be a nice fit with Dell's recent acquisition of SilverBack Technologies, which is also a remote services player.

Visit DealProfiles.com to check out other recent M&A deals.

Tom Taulli is the author of various books, including The Complete M&A Handbook and The Edgar Online Guide to Decoding Financial Statements.

Credit crunch? Not so for the venture capital space. According to various surveys, there is still lots of strength.

For example, the MoneyTree Report (from PricewaterhouseCoopers and the National Venture Capital Association) shows $7.1 billion in VC investments for the third quarter. A report from Dow Jones (NYSE: DJ) VentureOne shows about $8.1 billion in fundings.

It certainly helps that there has been a pick-up in the IPO market. Oh, and the tech sector has had a nice rally. The most popular categories for VCs include software and biotech.

As for software, there has been a megatrend for on-demand offerings. As seen with the growth of companies like Salesforce.com (NYSE: CRM), VMware (NYSE: VMW) and Taleo (NASDAQ: TLEO), the enthusiasm is certainly understandable.

However, I'm not so sure about biotech. The sector has been fairly weak in terms of public offerings. But, then again, it seems biotech companies always need to raise gobs of money, right?

Something else: There's been a pick-up in cleantech deals. After all, with high energy prices, there appears to be lots of opportunity.

Visit DealProfiles.com if you want to see other recent VC fundings.

Tom Taulli is the author of various books, including The Complete M&A Handbook and The Edgar Online Guide to Decoding Financial Statements.

MOST NOTEWORTHY: Cypress Bioscience, Banc of America, Insulet, Taleo and Vocus Inc were today's noteworthy initiations:

• Friedman Billings started shares of Cypress Biosciences Inc (NASDAQ: CYPB) with an Outperform rating and $22 target, and is positive on the company's lead product milnacipran, in Phase III studies for fibromyalgia. The firm expects a 1Q09 launch and believes the U.S. market could be as large as $7B.
  
• Goldman resumed coverage of Bank of America Corporation (NYSE: BAC) with a Buy rating and $63 target as they believe the company has around $22.5B of unrealized gains in its strategic investment portfolio. Goldman also added BAC to their Americas Buy List.
  
• Insulet Corporation (NASDAQ: PODD) was initiated at William Blair with an Outperform rating. The firm believes the unique features of the OmniPod will allow PODD to capture a meaningful portion of the 300,000 current insulin pumpers in the United States.
  
• Soleil started shares of Taleo Corporation (NASDAQ: TLEO) with a Buy rating and $35 target and believes the company's recent growth pace can continue.
  
• Shares of Vocus Inc (NASDAQ: VOCS) were also initiated at Soleil with a Buy rating and $39 target. The firm believes the company can gain share in the early stage market for public relations software given its on-demand model and low price entry point.

OTHER INITIATIONS:

• Cowen initiated shares of Lions Gate Entertainment Corp (NYSE: LGF) and Marvel Entertainment Inc (NYSE: MVL) with an Outperform rating and shares of Dreamworks Animation SKG Inc (NYSE: DWA) with a Neutral rating.
  
• Goldman resumed coverage of Nintendo Co Ltd (OTC: NTDOY) with a Buy rating.

Early this week, I met with Michael Gregoire, who is the CEO of Taleo Corp. (NASDAQ: TLEO). His company is a leader in HR software.

Instead of talking about the fine points of his industry or tech gobbledygook, he spent most of his time talking about the look-and-feel of his software and website. "If you go to Google (NASDAQ: GOOG) or Amazon.com (NASDAQ: AMZN), do you need a user manual?" he asked. "Of course not. It's natural. The technology doesn't get in the way."

In fact, over the past year, Gregoire has had a laser focus on improving his software's usability, and based on what I've seen so far, it's been well worth it. Interestingly enough, the system has the feel of Apple's (NASDAQ: AAPL) iPod, not a boring HR application. "We think design and usability will be a key differentiator going forward and very important for growth," said Gregoire.

So how can a small business make sure its products showcase good design and ease of use? Some entrepreneur's I've interviewed recently told me how they have been able to follow what I would call 'the iPod way.'

MOST NOTEWORTHY: European pharmaceuticals, Microsoft, Salesforce.com, Taleo and McAfee were today's noteworthy initiations:

• UBS resumed coverage of Novartis AG (NYSE: NVS) with a Buy rating and AstraZeneca (NYSE: AZN), Roche Holding (OTC: RHHBY), Sanofi-Aventis (NYSE: SNY) and GlaxoSmithKline (NYSE: GSK) with Neutral ratings.
  
• Deutsche Bank believes new product leverage can bring upside to consensus operating margin expectations at Microsoft Corporation (NASDAQ: MSFT) and they view shares as attractively valued given its growth profile. The firm started shares with a Buy rating and $33 target.
• Keybanc initiated shares of Salesforce.com (NYSE: CRM) with a Hold rating and sees slowing growth rates for revenue and net subscriber additions throughout the remainder of FY08 and beyond and thinks investor expectations are too high.
• Keybanc also started shares of Taleo Corporation (NASDAQ: TLEO) with a Buy rating and $27 target, as it is well-positioned to gain market share in the Human Capital Management space.
• Thomas Weisel believes McAfee Inc (NYSE: MFE) will benefit from PC market growth, enhanced awareness of the company's brand, and its renewed focus on product development for the midmarket corporate segment, and started shares with a Market Weight rating and $37 target.

OTHER INITIATIONS:

• Lululemon Athletica (NASDAQ: LULU) was started at William Blair with an Outperform rating and at UBS with a Neutral rating and $37 target.
• Merrill Lynch initiated shares of Zoltek Companies Inc (NASDAQ: ZOLT) with a Buy rating and $50 target.
• Bear Stearns started shares of Capital Product Partners (NASDAQ: CPLP) with a Peer Perform rating.
• Oppenheimer initiated shares of BFC Financial (NYSE: BFF) with a Buy rating and $3.50 target.

MOST NOTEWORTHY: Dendreon Corp (DNDN), Cubic Corp (CUB), Endo Pharmaceuticals (ENDO), Northrop Grumman (NOC) and Royal Dutch Shell (RDS.A) were today's notable downgrades:

• JMP Securities downgraded shares of Dendreon Corp (NASDAQ: DNDN) to Market Underperform from Market Perform based on the company's uncertain product pipeline and the recent SEC filing that revealed that certain officers and directors are facing potential shareholder lawsuits regarding trading activities.
  

• Friedman Billings cut Cubic Corp (AMEX: CUB) to Underperform from Market Perform on valuation.

• RBC Capital downgraded Endo Pharmaceuticals (OTCBB: ENDP) to Sector Perform from Outperform following the company's withdrawal of guidance pertaining to its NDA for the Ketoprofen patch.

• Northrop Grumman (NYSE: NOC) was cut to Neutral from Overweight at JP Morgan on valuation. UBS cut Royal Dutch Shell to Neutral from Buy on valuation...

OTHER DOWNGRADES:

• Robinson Humphries downgraded Ruby Tuesday (NYSE: RT) to Neutral from Buy.

• Montgomery downgraded shares of Taleo Corp (NASDAQ: TLEO) to Hold from Buy.

• Credit Suisse downgraded AutoZone (NYSE: AZO) to Neutral from Outperform.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

MOST NOTEWORTHY: TomoTherapy Inc (TTPY) and Anthracite Capital Inc (AHR) were today's notable initiations.

• TomoTherapy Inc (NASDAQ: TTPY) was initiated by a group of firms:

• Baird started TomoTherapy Inc with an Outperform rating, saying the Hi-Art system has several key competitive advantages that include a more conformal beam pattern, potential to better measure radiation dose delivery and greater ability to treat complex cases.

• William Blair and Piper Jaffray both believe the company has a substantial infrastructure to manufacture and support strong growth beyond the current 125 systems in the field, and started shares with an Outperform rating.

• Deutsche Bank initiated Anthracite Capital (NYSE: AHR) with a Hold rating, expecting the company to continue growing its portfolio by acquiring commercial real estate securities and CRE loans...

OTHER INITIATIONS:

• Lehman started Evergreen Solar (NASDAQ: ESLR) with an Equal Weight rating.

• Taleo Corp (NASDAQ: TLEO) was reinstated with a Buy rating at ThinkEquity.

• Needham initiated Spectrum Control, Inc (NASDAQ: SPEC) with a Buy rating.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required).